Navigation Links
ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
Date:4/23/2009

proximately 3.2 million people in the United States and approximately 170 million people worldwide. HCV causes inflammation of the liver, which can lead to fibrosis and cirrhosis, and may ultimately lead to liver failure and/or liver cancer if not successfully treated. Cirrhosis of the liver resulting from chronic HCV infection is the leading indication for liver transplantation in the U.S. Due to the asymptomatic nature of HCV infection, it often goes undetected for up to 20 years following initial infection. Each year, 8,000 to 10,000 people in the U.S. die from complications of HCV.

The current standard of care is a combination of pegylated interferon and ribavirin. Inadequate response rates, in particular for patients infected with genotype 1 HCV, along with significant side effects of approved therapy, support the medical need for improved treatment options. It is estimated that fewer than 5% of people with chronic HCV infection living in the U.S. are under treatment today. Most infected individuals are unaware of their infection status and the large majority of individuals who know their condition do not currently receive drug therapy. There is also a growing number of individuals who have failed interferon-based regimens who may be successfully treated with combinations of two or more direct antivirals. It is expected that the next generation of therapies for treatment of HCV will include small molecules, such as ANA598, that directly act upon specific viral enzymes to inhibit viral replication. These new therapies are expected to improve overall therapy by increasing cure rates and potentially improving tolerability and convenience of treatment if doses of currently used agents can be reduced or eliminated.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology.
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
2. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
3. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
6. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
9. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
10. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
11. Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Champions Biotechnology, Inc . (OTC ... development of advanced preclinical platforms and tumor specific ... today announced its financial results for the second ... details of Company,s financial results are available in ... ,, Total revenues for the second quarter of ...
(Date:12/15/2009)... the newly formed industry, community and education initiative to ... County, is working to connect the orthopedics capital of ... via high-speed rail. ,, In a September report, ... the World -- An overview, analysis and blueprint ... the statewide initiative to grow Indiana,s unique life sciences ...
(Date:12/15/2009)... 15 Medical researchers with EDP Biotech ... revolutionary new technology for a simple blood test ... Following the success of its pre-clinical trials for ... on the biomarker, CA11-19, and all aspects of ... ColoMarker(TM) will detect colon cancer in its earliest, ...
Breaking Medicine Technology:Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Pharmacy Times Names New Editorial Director 53496 1Pharmacy Times Names New Editorial Director 53496 2Five Questions About Protopic 28tacrolimus 29 Ointment 13332 1Five Questions About Protopic 28tacrolimus 29 Ointment 13332 2Five Questions About Protopic 28tacrolimus 29 Ointment 13332 3Five Questions About Protopic 28tacrolimus 29 Ointment 13332 4Why anorexic patients cling to their eating disorder 53489 1Why anorexic patients cling to their eating disorder 53489 2
(Date:12/15/2009)... Lady of Lourdes Health Care Services Inc., the parent ... pay the United States $7.95 million to resolve allegations ... today. The two hospitals are Our Lady of Lourdes ... Center of Burlington County (LMC) in Willingboro, N.J. ... by a whistleblower, Tony Kite, in 2005. The lawsuit ...
(Date:12/15/2009)... risk, research finds , , TUESDAY, Dec. 15 (HealthDay News) ... regulates appetite, may guard against Alzheimer,s disease, new research ... may be one of many agents that we use ... study author Dr. Sudha Seshadri, an associate professor of ... may be one of many markers that we measure ...
(Date:12/15/2009)... American Diabetes Association and the CDC have released some sobering statistics ... United States. Treadmill desks offer employers an effective means of combating ... ... (Vocus) December 14, 2009 -- Rates of diabetes are climbing across ... obesity rates. Despite this rise the American Diabetes Association has stated ...
(Date:12/15/2009)... PARK, Calif., Dec. 15 ... position in the pharmaceutical and bio-tech research ... Marketing Research). Over the past 11 years ... the Physicians Consulting Network (PCN®), which now ... professionals covering both primary care and hard-to-reach ...
(Date:12/15/2009)... 15 Patient advocate ... Members of Congress that, "it doesn,t matter whether there,s ... - without a public option - give government authority ... also fund a new social agenda by shifting billions ... groups, newly arriving immigrants, and local politicians." ...
Breaking Medicine News(10 mins):Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2
... Avon Global Center for Women and Justice at ... Trust Fund to End Violence Against Women Award-Winning Actress ... 3 One in three women worldwide experience violence ... is assaulted every nine seconds(2). Around the world, services ...
... wristbands enable fast and reliable patient identification at ... Zebra Technologies (Nasdaq: ZBRA ), ... solutions for the healthcare industry, has introduced a ... Z-Band QuickClip wristbands for infants to ensure comfort ...
... In 2006, Americans were exposed to more than seven ... was the case in the early 1980s, according to ... by the National Council on Radiation Protection and Measurements ... 2006, medical exposure constituted nearly half of the total ...
... mouse study finds , , TUESDAY, March 3 (HealthDay News) ... also becomes active in the fat tissue of obese mice ... say researchers. They also found that blocking this signal in ... Previous research found that the CREB pathway keeps blood sugar ...
... breakthrough strategy to improve the effectiveness of the only ... the deadly disease in a pre-clinical test, report scientists ... Houston in Nature Medicine ,s Advance Online Publication ... years of research funded by the National Institutes of ...
... from the Convenience of a Computer, www.CardioCareLive.com takes place entirely ... to 8:00 PM Eastern.,Patch Adams, MD, the real physician behind the ... now for free, visit cardioCareLive.com. , ... Needham, MA ...
Other Medicine News:Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 2Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 3Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 4Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 5Health News:Video: Avon Commits Over $1.75 Million for New Partnerships to End Violence Against Women 6Health News:Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort 2Health News:Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort 3Health News:Medical Radiation Exposure of the U.S. Population Greatly Increased Since the Early 1980s 2Health News:'Fasting Signal' Offers Clues to Insulin Resistance in the Obese 2Health News:TB breakthrough could lead to stronger vaccine 2Health News:TB breakthrough could lead to stronger vaccine 3Health News:CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: